Dolby Laboratories (NYSE:DLB) Releases FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.190-4.340 for the period, compared to the consensus earnings per share estimate of 3.770. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q1 2026 guidance to 0.790-0.940 EPS.

Dolby Laboratories Trading Up 0.9%

NYSE DLB traded up $0.58 during trading on Tuesday, hitting $65.13. The company had a trading volume of 908,218 shares, compared to its average volume of 455,711. The company’s fifty day moving average is $69.07 and its 200-day moving average is $72.58. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66. The company has a market cap of $6.24 billion, a price-to-earnings ratio of 23.86 and a beta of 0.97.

Analyst Upgrades and Downgrades

DLB has been the subject of a number of research reports. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Robert W. Baird started coverage on Dolby Laboratories in a report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 12th. Rosenblatt Securities restated a “buy” rating and set a $95.00 price target on shares of Dolby Laboratories in a research report on Friday, August 1st. Finally, Tigress Financial increased their price objective on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Dolby Laboratories presently has an average rating of “Moderate Buy” and a consensus price target of $95.75.

Insider Buying and Selling at Dolby Laboratories

In other news, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This represents a 9.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Kevin J. Yeaman sold 25,000 shares of the firm’s stock in a transaction on Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at $7,901,110.75. The trade was a 17.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 57,000 shares of company stock worth $4,037,690 over the last three months. Corporate insiders own 38.39% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in DLB. Boothbay Fund Management LLC increased its position in shares of Dolby Laboratories by 4.1% during the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock valued at $299,000 after acquiring an additional 157 shares in the last quarter. Raymond James Financial Inc. increased its holdings in shares of Dolby Laboratories by 1.0% in the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock worth $1,808,000 after purchasing an additional 235 shares in the last quarter. Cresset Asset Management LLC raised its stake in shares of Dolby Laboratories by 10.7% in the third quarter. Cresset Asset Management LLC now owns 2,991 shares of the electronics maker’s stock worth $216,000 after purchasing an additional 290 shares during the last quarter. US Bancorp DE raised its stake in shares of Dolby Laboratories by 31.3% in the third quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock worth $103,000 after purchasing an additional 341 shares during the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC lifted its holdings in shares of Dolby Laboratories by 15.5% during the third quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,083 shares of the electronics maker’s stock valued at $295,000 after purchasing an additional 549 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.